Deferred Tax Assets, Valuation Allowance of Generation Bio Co. from 31 Dec 2018 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Generation Bio Co. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2018 to 31 Dec 2024.
  • Generation Bio Co. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $214,316,000, a 22% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Generation Bio Co. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $214,316,000 +$38,774,000 +22% 31 Dec 2024 10-K 13 Mar 2025 2024 FY
Q4 2023 $175,542,000 +$37,684,000 +27% 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q4 2022 $137,858,000 +$38,956,000 +39% 31 Dec 2022 10-K 13 Mar 2025 2024 FY
Q4 2021 $98,902,000 +$37,934,000 +62% 31 Dec 2021 10-K 06 Mar 2024 2023 FY
Q4 2020 $60,968,000 +$27,855,000 +84% 31 Dec 2020 10-K 23 Feb 2023 2022 FY
Q4 2019 $33,113,000 +$18,867,000 +132% 31 Dec 2019 10-K 24 Feb 2022 2021 FY
Q4 2018 $14,246,000 31 Dec 2018 10-K 18 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.